ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine.

Y Hamon, C Broccardo, O Chambenoit, MF Luciani… - Nature cell …, 2000 - nature.com
ATP-binding-cassette transporter 1 (ABC1) has been implicated in processes related to
membrane-lipid turnover. Here, using in vivo loss-of-function and in vitro gain-of-function models…

Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice

…, G Liebisch, W Drobnik, A Götz, O Chambenoit… - Nature …, 2000 - nature.com
Mutations in the gene encoding ATP-binding cassette transporter 1 (ABC1) have been reported
in Tangier disease 1, 2, 3 (TD), an autosomal recessive disorder that is characterized by …

[HTML][HTML] Specific docking of apolipoprotein AI at the cell surface requires a functional ABCA1 transporter

O Chambenoit, Y Hamon, D Marguet… - Journal of Biological …, 2001 - ASBMB
The identification of defects in ABCA1 as the molecular basis of Tangier disease has
highlighted its crucial role in the loading with phospholipids and cholesterol of nascent …

ABCA1 and the engulfment of apoptotic cells

Y Hamon, O Chambenoit, G Chimini - … (BBA)-Molecular and Cell Biology of …, 2002 - Elsevier
Programmed cell death is one of the major devices controlling cellular homeostasis.
However, the generation of cell debris that follows the execution phase of apoptosis has to be …

Persistence and adherence of biologics in US patients with psoriatic arthritis: analyses from a claims database

KR Oelke, O Chambenoit, AQ Majjhoo… - Journal of …, 2019 - becarispublishing.com
Aim: To evaluate the persistence and adherence of subcutaneous biologics in patients with
psoriatic arthritis (PsA). Patients & methods: Psoriatic arthritis patients who initiated …

Omalizumab re-treatment and step-up in patients with chronic spontaneous urticaria: OPTIMA trial

…, K Papp, M Gooderham, O Chambenoit… - The Journal of Allergy …, 2020 - Elsevier
Background Omalizumab shows greater clinical benefit with 300 mg dose than with the 150
mg dose. Objective To determine outcomes postwithdrawal, relapse, and re-treatment in …

[HTML][HTML] Distinct sites on ABCA1 control distinct steps required for cellular release of phospholipids1s□

V Rigot, Y Hamon, O Chambenoit, M Alibert… - Journal of lipid …, 2002 - ASBMB
The loss of ABCA1 function leads to Tangier dyslipidemia in humans and to a Tangier-like
phenotype in mice, by impairing the transformation of nascent apolipoproteins into mature …

Secukinumab in United States biologic-naïve patients with psoriatic arthritis: results from the randomized, placebo-controlled CHOICE study

…, C Rollins, R Calheiros, O Chambenoit - The Journal of …, 2022 - jrheum.org
Objective To evaluate secukinumab (SEC) 300 mg and 150 mg vs placebo in a United
States–only population of biologic-naïve patients with psoriatic arthritis (PsA). Methods CHOICE …

[HTML][HTML] Secukinumab efficacy on psoriatic arthritis GRAPPA-OMERACT core domains in patients with or without prior tumor necrosis factor inhibitor use: pooled …

…, S Siebert, W Tillett, M Vis, O Chambenoit… - Rheumatology and …, 2021 - Springer
Background Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated disease
manifesting as a spectrum of possible inflammatory signs and symptoms. Clinicians need …

Construction and functional screening of a metagenomic library using a T7 RNA polymerase-based expression cosmid vector

FX Lussier, O Chambenoit, A Côté… - Journal of Industrial …, 2011 - academic.oup.com
The metagenomic approach has greatly accelerated the discovery of new enzymes by giving
access to the genetic potential of microorganisms from various environments. Function-…